/AMBEA.ST

AMBEA.ST Stock - Ambea AB (publ)

Q: What is the analyst price target for AMBEA.ST?

Analyst price target information is not currently available for AMBEA.ST.

Q: What is AMBEA.ST's market cap?

Market capitalization information is not currently available for AMBEA.ST.

Healthcare|Medical - Care Facilities|STO

$141.30-0.07%

$0.10 (-0.07%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $155.43

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AMBEA.ST

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.86

52W High$143.60

52W Low$88.95

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$14.20B	$13.31B	$12.63B	$11.48B	$11.08B
Gross Profit	$2.44B	$3.44B	$12.19B	$11.06B	$10.72B
Gross Margin	17.2%	25.8%	96.5%	96.3%	96.8%
Operating Income	$1.28B	$981.00M	$843.00M	$598.00M	$717.00M
Net Income	$620.00M	$455.00M	$366.00M	$237.00M	$359.00M
Net Margin	4.4%	3.4%	2.9%	2.1%	3.2%
EPS	$7.21	$5.07	$3.89	$2.51	$3.80

Company Overview

Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark. The company operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The Nytida segment comprises residential facilities, support for individuals and families, schools for children, young people and adults with disabilities or psychosocial problems, and day services. The Vardaga segment offers nursing homes, short-term residential facilities, home care, and day services for elderly people. The Stendi segment provides for children, young people, adults by offering personal assistance, residential care, elderly care, and home care. The Altiden segment comprises operations in elderly care, home care, social care, and disability care. The Klara segment offers subscription services for ambulatory care teams; and a supply of temporary doctors and nurses. Ambea AB (publ) was founded in 1996 and is headquartered in Solna, Sweden.

Visit Website

Earnings History & Surprises

AMBEA.ST

Beat Rate

50%

Last 18 quarters

Avg Surprise

-1.3%

EPS vs Estimate

Beats / Misses

9/8

1 met exactly

Latest EPS

$3.82

Q4 2025

EPS Surprise History

Q1 24

+92.2%

$1.48vs$0.77

Q2 24

+10.6%

$1.25vs$1.13

Q3 24

0.0%

$1.09vs$1.09

Q4 24

+13.8%

$3.13vs$2.75

Q1 25

-1.7%

$1.75vs$1.78

Q2 25

+10.3%

$1.39vs$1.26

Q3 25

-68.4%

$1.13vs$3.58

Q4 25

+42.5%

$3.82vs$2.68

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 4, 2026	—	—	—	—
Q1 2026	Feb 12, 2026	—	—	—	—
Q4 2025	Nov 5, 2025	$2.68	$3.82	+42.5%	✓ BEAT
Q3 2025	Aug 19, 2025	$3.58	$1.13	-68.4%	✗ MISS
Q2 2025	May 6, 2025	$1.26	$1.39	+10.3%	✓ BEAT
Q1 2025	Feb 12, 2025	$1.78	$1.75	-1.7%	✗ MISS
Q4 2024	Nov 6, 2024	$2.75	$3.13	+13.8%	✓ BEAT
Q3 2024	Aug 16, 2024	$1.09	$1.09	0.0%	= MET
Q2 2024	May 3, 2024	$1.13	$1.25	+10.6%	✓ BEAT
Q1 2024	Feb 8, 2024	$0.77	$1.48	+92.2%	✓ BEAT
Q4 2023	Nov 2, 2023	$2.08	$2.30	+10.6%	✓ BEAT
Q3 2023	Aug 17, 2023	$0.43	$0.51	+18.6%	✓ BEAT
Q2 2023	May 4, 2023	$0.69	$0.77	+11.6%	✓ BEAT
Q1 2023	Feb 9, 2023	$0.92	$0.24	-73.9%	✗ MISS
Q4 2022	Nov 3, 2022	$2.09	$2.04	-2.4%	✗ MISS
Q3 2022	Aug 18, 2022	$0.70	$0.91	+30.0%	✓ BEAT
Q2 2022	May 4, 2022	$1.08	$0.70	-35.2%	✗ MISS
Q1 2022	Feb 9, 2022	$1.35	$1.14	-15.6%	✗ MISS
Q4 2021	Nov 4, 2021	$2.09	$2.01	-3.8%	✗ MISS
Q3 2021	Jul 23, 2021	$1.04	$0.39	-62.5%	✗ MISS

Frequently Asked Questions about AMBEA.ST

What is AMBEA.ST's current stock price?

Ambea AB (publ) (AMBEA.ST) is currently trading at $141.30 per share. The stock has moved -0.07% today.

What is the analyst price target for AMBEA.ST?

No analyst price targets are currently available for this stock.

What sector is Ambea AB (publ) in?

Ambea AB (publ) operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the STO exchange.

What is AMBEA.ST's market cap?

Ambea AB (publ) has a market capitalization of $11.88 billion, making it a large-cap company.

Does AMBEA.ST pay dividends?

No, Ambea AB (publ) does not currently pay a dividend to shareholders.